References
- Pankey GA.Tigecycline. J Antimicrob Chemother. 2005; 56: 470–80.
- Frampton JE, Curran MP.Tigecycline. Drugs. 2005; 65: 2623–35.
- Rubinstein E, Vaughan D.Tigecycline: a novel glycylcy-cline. Drugs. 2005; 56: 1317–36.
- Rose WE, Rybak MJ.Tigecycline: first of a new class of antimicrobial agents. Pharmacotherapy. 2006; 1099-1100.
- Fraise P. Adam. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance. J Infect 2006; 53: 293–300.
- Giamarellou H, Treatment options for multidrug-resistant bacteria. Expert Rev Anti-Infect Ther. 2006; 4: 601–18.
- Garrelts JC. Schroeder T. Tigecycline: place in therapy and important considerations. Am J Health Syst Pharm. 2006; 63: 1233.
- Kasbekar N. Tigecycline: a new glycylcycline antimicro-bial agent. Am J Health Syst Pharm. 2006; 63: 1235–43.
- Peterson LR. Antimicrobial activity and pharmacokinet-ics/pharmacodynamics of the novel glycylcycline, tigecycline. Diagn Microbiol Infect Dis. 2005; 52: 163–4.
- Cunha BA, Domenico PD, Cunha CB. Pharmacodynamics of doxycycline. Clin Microbiol Infect Dis. 2000; 6: 270–273.